Current Paediatrics
Volume 13, Issue 3 , Pages 213-220, June 2003

Management of germ cell tumours in childhood

  • Roger D Palmer

      Affiliations

    • Specialist Registrar, UK
    • Corresponding Author InformationCorrespondence to: JPH. Tel.: +44 (0) 191-282 4101; Fax: +44 (0 ) 191-202 3060
  • ,
  • James C Nicholson

      Affiliations

    • Consultant Paediatric Oncologist, Department of Paediatric Oncology, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK
  • ,
  • Juliet P Hale

      Affiliations

    • Consultant Paediatric Oncologist and Chair of the UKCCSG Germ Cell Working Group, Department of Paediatric Oncology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK

Abstract 

Germ cell tumours are a group of rare benign and malignant neoplasms of unknown cause, and may be gonadal or extragonadal (intracranial or extracranial). Teratomas are the most common and are usually benign. Malignant germ cell tumours often secrete the tumour markers alpha-fetoprotein and human chorionic gonadotrophin, which are useful in diagnosis and monitoring. The treatment is surgical for teratoma and non-metastatic gonadal tumours. Chemotherapy, reserved in the UK for stage 2–4 extracranial malignant germ cell tumours, achieves a 5-year survival of around 90%. Intracranial tumours are typically pineal or suprasellar. Intracranial germinomas are cured in over 90% of cases with radiotherapy or combined chemoradiotherapy, whereas non-germinomatous tumours fare less well despite combination chemotherapy and radiotherapy.

Keywords:  neoplasms, germ cell, infant/child/adolescent, neoplasms/gonadal/extragonadal, neoplasms, intracranial and antineoplastic combined chemotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0957-5839(03)00021-6

doi:10.1016/S0957-5839(03)00021-6

Current Paediatrics
Volume 13, Issue 3 , Pages 213-220, June 2003